Overview

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This exploratory study is designed to determine the early viral kinetic profile during treatment with telbivudine or entecavir at multiple time points over 12 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Entecavir
Telbivudine